Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women

Neurology

Volumn 80, Issue 10, 2013, Pages 911-918

  Raz, Limor ^a   Jayachandran, M ^a   Tosakulwong, Nirubol ^a   Lesnick, Timothy G ^a   Wille, Samantha M ^a   Murphy, Matthew C ^a   Senjem, Matthew L ^a   Gunter, Jeffrey L ^a   Vemuri, Prashanthi ^a   Jack, Clifford R ^a   Miller, Virginia M ^a   Kantarci, Kejal ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER; CONJUGATED ESTROGEN; ESTRADIOL; FIBRINOGEN RECEPTOR; PLACEBO; PROGESTERONE;

ADULT; ALGORITHM; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUTOMATION; BRAIN SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; FEMALE; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOGENIC MICROVESICLE; WHITE MATTER;

EID: 84876213501     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182840c9f     Document Type: Article

References (38)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
2. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 2008;39:2712-2719.
3. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643-647.
4. Kantarci K, Weigand SD, Przybelski SA, et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 2009;72:1519-1525.
5. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008;71:108-113.
6. Swartz RH, Stuss DT, Gao F, Black SE. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 2008;39:822-830.
7. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 2009;40:S48-S52.
8. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35:1857-1861.
9. Fernando MS, O'Brien JT, Perry RH, et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 2004;30:385-395.
10. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461-468.
11. Raz N, Yang Y, Dahle CL, Land S. Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta 2012;1822:361-369.
12. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009;73:120-125.
13. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
14. Horstman LL, Jy W, Bidot CJ, et al. Potential roles of cell-derived microparticles in ischemic brain disease. Neurol Res 2009;31:799-806.
15. Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years after eclampsia. Am J Obstet Gynecol 2009;200:e501-e505.
16. Aukes AM, Wessel I, Dubois AM, Aarnoudse JG, Zeeman GG. Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol 2007;197: e361-e366.
17. Jayachandran M, Litwiller RD, Lahr BD, et al. Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res 2011;4:811-822.
18. Miller VM, Jayachandran M, Hashimoto K, Heit JA, Owen WG. Estrogen, inflammation, and platelet phenotype. Gend Med 2008;5:S91-S102.
19. Romero JR, Beiser A, Seshadri S, et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham Study. Stroke 2009;40:1590-1596.
20. Harman SM, Brinton EA, Cedars M, et al. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3-12.
21. Jayachandran M, Litwiller RD, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008;295:931-938.
22. Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009;2:228-239.
23. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
24. McBane RD II, Karnicki K, Tahirkheli N, Miller RS, Owen WG. Platelet characteristics associated with coronary artery disease. J Thromb Haemost 2003;1:1296-1303.
25. Jayachandran M, Miller VM, Heit JA, Owen WG. Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods 2012;375:207-214.
26. Rostrup E, Gouw AA, Vrenken H, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors: results from the LADIS study. Neuroimage 2012;60:1597-1607.
27. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923.
28. Matthews KA, Santoro N, Lasley B, et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 2006;91:1789-1795.
29. Saji N, Shimizu H, Kawarai T, Tadano M, Kita Y, Yokono K. Increased brachial-ankle pulse wave velocity is independently associated with white matter hyperintensities. Neuroepidemiology 2011;36:252-257.
30. Kuller LH, Margolis KL, Gaussoin SA, et al. Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS): MRI trial. J Clin Hypertens 2010;12:203-212.
31. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ. Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the HonoluluAsia Aging Study. Stroke 2002;33:26-30.
32. Inaba M, White L, Bell C, et al. White matter lesions on brain magnetic resonance imaging scan and 5-year cognitive decline: the Honolulu-Asia Aging Study. J Am Geriatr Soc 2011;59:1484-1489.
33. Miller VM, Jayachandran M, Owen WG. Ageing, oestrogen, platelets and thrombotic risk. Clin Exp Pharmacol Physiol 2007;34:814-821.
34. Xiong J, Miller VM, Li Y, Jayachandran M. Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol 2012;59:124-132.
35. Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40:1229-1236.
36. Rosenkranz M, Thomalla G, Havemeister S, et al. Older age and greater carotid intima-media thickness predict ischemic events associated with carotid-artery stenting. Cerebrovasc Dis 2010;30:567-572.
37. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
38. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011;69:928-939.